Key result
Persistent resistant hypertension was associated with a 2.2-fold increased risk for the composite of coronary artery disease and stroke compared with never having resistant hypertension (95% CI 1.21-4.05; P=0.01).
Why the study?
Does persistent resistant hypertension increase the risk of cardiovascular morbidity in treated hypertensive patients?
Cohort (n=1,911)
Does persistent resistant hypertension increase the risk of cardiovascular morbidity in treated hypertensive patients?
Hazard Ratio: 2.2 (95% CI 1.21–4.05)
p-value: p=0.01
Persistent resistant hypertension is common and independently associated with a significantly increased risk of cardiovascular morbidity compared to non-resistant hypertension.
May warrant closer surveillance in persistent resistant hypertension; leaves open whether targeted interventions reduce events.
OBJECTIVE: Little is known regarding the clinical course and prognosis of resistant hypertension (RHT). We evaluated predictors of persistent RHT and the associated cardiovascular risk. METHODS: We studied 1911 treated hypertensive patients (aged 59±11 years, 49% men) for a mean period of 3.9 years. At baseline, clinical data were collected and patients underwent echocardiographic measurements, routine blood testing and additional workup for exclusion of secondary causes of RHT (office-based uncontrolled hypertension under at least three drugs including a diuretic or controlled hypertension under four or more drugs). Endpoint of interest was the composite of coronary artery disease and stroke. MAIN RESULTS: Four groups were identified depending on presence or absence of RHT at baseline and follow-up: 1153 patients (60%) never having RHT, 189 (10%) with resolved RHT, 204 (11%) with incident RHT and 365 (19%) with persistent RHT. Two-thirds of the patients with RHT at baseline remained resistant at the end of the study. Independent variables associated with both incident and persistent RHT were diabetes mellitus, history of cardiovascular disease, hypertension duration, SBP, left ventricular hypertrophy and glomerular filtration rate. Persistent RHT compared with never-having RHT was associated with a 2.2-fold increased risk for cardiovascular morbidity (95% CI: 1.21-4.05, P = 0.01) after adjustment for risk factors. CONCLUSION: In treated hypertensive patients, among prospective RHT dynamic patterns, persistent RHT is frequent and independently associated with adverse cardiovascular prognosis.
No takes yet. Share an insight, caveat, or question.
Tsioufis et al. (2013) conducted a cohort in Resistant hypertension (n=1,911). Persistent resistant hypertension vs. Never having resistant hypertension was evaluated on Composite of coronary artery disease and stroke (HR 2.2, 95% CI 1.21-4.05, p=0.01). Persistent resistant hypertension was associated with a 2.2-fold increased risk for the composite of coronary artery disease and stroke compared with never having resistant hypertension (95% CI 1.21-4.05; P=0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: